Treatment effects in prostate cancer following traditional and emerging therapies

R. Mazzucchelli, M. Scarpelli, A. Lopez-Beltran, Liang Cheng, R. Di Primio, R. Montironi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Treatment options for prostate cancer consist of radical prostatectomy, hormonal therapy and radiation therapy. Hormonal and radiation therapy have well-known, often profound, effects on the histological appearance of benign and malignant prostate tissue. Novel therapies including focal ablative treatments, chemotherapies and targeted molecular therapies are beginning to emerge and pathologists will play a central role in documenting the effects of these treatments at the tissue level. As such, knowledge of treatment-related changes and access to clinical information are essential to ensure accurate interpretation and reporting of post-treatment prostate specimens by pathologists.

Original languageEnglish
Pages (from-to)291-298
Number of pages8
JournalInternational Journal of Immunopathology and Pharmacology
Volume26
Issue number2
StatePublished - Apr 2013

Fingerprint

Prostatic Neoplasms
Therapeutics
Prostate
Radiotherapy
Molecular Targeted Therapy
Access to Information
Prostatectomy
Drug Therapy

Keywords

  • Prostate cancer
  • Treatment effects

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy

Cite this

Mazzucchelli, R., Scarpelli, M., Lopez-Beltran, A., Cheng, L., Di Primio, R., & Montironi, R. (2013). Treatment effects in prostate cancer following traditional and emerging therapies. International Journal of Immunopathology and Pharmacology, 26(2), 291-298.

Treatment effects in prostate cancer following traditional and emerging therapies. / Mazzucchelli, R.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, Liang; Di Primio, R.; Montironi, R.

In: International Journal of Immunopathology and Pharmacology, Vol. 26, No. 2, 04.2013, p. 291-298.

Research output: Contribution to journalArticle

Mazzucchelli, R, Scarpelli, M, Lopez-Beltran, A, Cheng, L, Di Primio, R & Montironi, R 2013, 'Treatment effects in prostate cancer following traditional and emerging therapies', International Journal of Immunopathology and Pharmacology, vol. 26, no. 2, pp. 291-298.
Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Di Primio R, Montironi R. Treatment effects in prostate cancer following traditional and emerging therapies. International Journal of Immunopathology and Pharmacology. 2013 Apr;26(2):291-298.
Mazzucchelli, R. ; Scarpelli, M. ; Lopez-Beltran, A. ; Cheng, Liang ; Di Primio, R. ; Montironi, R. / Treatment effects in prostate cancer following traditional and emerging therapies. In: International Journal of Immunopathology and Pharmacology. 2013 ; Vol. 26, No. 2. pp. 291-298.
@article{180ab23179c5437da3f76e95ab2dd806,
title = "Treatment effects in prostate cancer following traditional and emerging therapies",
abstract = "Treatment options for prostate cancer consist of radical prostatectomy, hormonal therapy and radiation therapy. Hormonal and radiation therapy have well-known, often profound, effects on the histological appearance of benign and malignant prostate tissue. Novel therapies including focal ablative treatments, chemotherapies and targeted molecular therapies are beginning to emerge and pathologists will play a central role in documenting the effects of these treatments at the tissue level. As such, knowledge of treatment-related changes and access to clinical information are essential to ensure accurate interpretation and reporting of post-treatment prostate specimens by pathologists.",
keywords = "Prostate cancer, Treatment effects",
author = "R. Mazzucchelli and M. Scarpelli and A. Lopez-Beltran and Liang Cheng and {Di Primio}, R. and R. Montironi",
year = "2013",
month = "4",
language = "English",
volume = "26",
pages = "291--298",
journal = "International Journal of Immunopathology and Pharmacology",
issn = "0394-6320",
publisher = "Biomedical Research Press s.a.s.",
number = "2",

}

TY - JOUR

T1 - Treatment effects in prostate cancer following traditional and emerging therapies

AU - Mazzucchelli, R.

AU - Scarpelli, M.

AU - Lopez-Beltran, A.

AU - Cheng, Liang

AU - Di Primio, R.

AU - Montironi, R.

PY - 2013/4

Y1 - 2013/4

N2 - Treatment options for prostate cancer consist of radical prostatectomy, hormonal therapy and radiation therapy. Hormonal and radiation therapy have well-known, often profound, effects on the histological appearance of benign and malignant prostate tissue. Novel therapies including focal ablative treatments, chemotherapies and targeted molecular therapies are beginning to emerge and pathologists will play a central role in documenting the effects of these treatments at the tissue level. As such, knowledge of treatment-related changes and access to clinical information are essential to ensure accurate interpretation and reporting of post-treatment prostate specimens by pathologists.

AB - Treatment options for prostate cancer consist of radical prostatectomy, hormonal therapy and radiation therapy. Hormonal and radiation therapy have well-known, often profound, effects on the histological appearance of benign and malignant prostate tissue. Novel therapies including focal ablative treatments, chemotherapies and targeted molecular therapies are beginning to emerge and pathologists will play a central role in documenting the effects of these treatments at the tissue level. As such, knowledge of treatment-related changes and access to clinical information are essential to ensure accurate interpretation and reporting of post-treatment prostate specimens by pathologists.

KW - Prostate cancer

KW - Treatment effects

UR - http://www.scopus.com/inward/record.url?scp=84881255157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881255157&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 291

EP - 298

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

SN - 0394-6320

IS - 2

ER -